Skip to content

EU Vaccine Strategy

Date de l'événement: 07/01/2021

EU Vaccine Strategy

Developing and deploying an effective and safe vaccine worldwide is likely to be the only way to end the COVID-19 pandemic. To this end, the Commission has proposed an EU vaccines strategy for COVID-19 and listed key steps for effective vaccination strategies and vaccine deployment.

The Commission has also entered into advance purchase agreements with several pharmaceutical laboratories in order to create a portfolio of potential vaccines against COVID-19 (Coronavirus). Any vaccine must be authorised by the European Medicines Agency (EMA) in accordance with safety and efficacy standards.

Fil d’actualités

Members of Committee on Environment, Public Health and Food Safety (ENVI) and Committee on Industry, Research and Energy (ITRE) participate in a joint meeting in the European Parliament in Brussels.

Afficher uniquement les médias connexes.

MEPs are expected to reiterate their support for a united EU approach to COVID-19 vaccines in a debate with Commission President von der Leyen.

Afficher uniquement les médias connexes.

Presentation by Sandra GALLINA, Director General for Health and Food Safety, DG SANTE, European Commission

Afficher uniquement les médias connexes.

MEPs debate the need for more clarity and transparency regarding vaccine contracts, authorisation, availability and deployment of COVID-19 vaccines.

Afficher uniquement les médias connexes.

Webstreaming (4)